Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis (Q33375111)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis |
scientific article |
Statements
1 reference
Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis (English)
1 reference
Jean-Louis Pujol
1 reference
Sofia Paul
1 reference
Nadia Chouaki
1 reference
Patrick Peterson
1 reference
Patti Moore
1 reference
Donald A Berry
1 reference
Marc Salzberg
1 reference
1 May 2007
1 reference
1 reference
397-401
1 reference
Identifiers
1 reference